Agios Pharmaceuticals AGIO announced that the FDA has approved Aqvesme (mitapivat) for the treatment of adult patients with alpha- or beta-thalassemia. With this approval, Aqvesme becomes the only FDA ...

Patients who received red blood cell transfusions experienced modestly higher resource use but no acute complications. Red blood cell (RBC) transfusion among hospitalized adults with warm autoimmune ...

Thalassemia patients on Friday hailed the introduction of the National Blood Transfusion Bill in Parliament and urged members to pass the life-saving bill at the earliest. Earlier this month, during ...

Outrage has trailed the decision of a Lagos-based breast cancer patient, Mensah Omolola, popularly known on X as Auntie Esther, to reject a medically advised blood transfusion, weeks after Nigerians ...

HDFN remained the leading indication for exchange transfusion, accounting for 67% of cases, primarily driven by anti-D alloimmunization (65.9%). Neonatal exchange transfusions in Serbia have declined ...

NEW ORLEANS, LA—For patients at high cardiac risk who undergo major general or vascular surgery, a liberal approach to transfusion is no better than the more commonly accepted restrictive approach ...

ABSTRACT: Hemolytic Disease of the Fetus and Newborn (HDFN) results from fetal-maternal blood group incompatibility, particularly involving the RhD antigen. Despite preventive strategies, HDFN remains ...

Abstract: Blood group typing is a critical procedure in transfusion medicine, organ transplantation, and pregnancy management. Ensuring patient safety requires accurate and rapid blood typing, as ...

Please provide your email address to receive an email when new articles are posted on . Practice patterns vary widely for management of hemolytic disease of the fetus and newborn (HDFN). Researchers ...